Pharma.AI

HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...

CAMBRIDGE, Mass., July 7, 2026 Insilico Medicine has announced the initiation of its Phase III clinical trial evaluating Rentosertib,...

SALT LAKE CITY, Utah, July 1, 2026 PolarityBio has announced the submission of a Biologics License Application (BLA) to...

CAMBRIDGE, Mass., July 2, 2026 Insilico Medicine has entered into a strategic collaboration with Takeda to accelerate the discovery...

BOSTON, MA and SEOUL, South Korea, June 22 2026 Insilico Medicine and SK Biopharmaceuticals have announced a landmark artificial...

Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...

Hong Kong | March 30, 2026 AI Collaboration Accelerates CNS Drug Discovery Insilico Medicine and Tenacia Biotechnology have announced...

March 3, 2026 Insilico Medicine, a clinical-stage biotechnology company known for its generative artificial intelligence platforms, has launched a...